343 related articles for article (PubMed ID: 31990905)
1. Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?
Sundström K; Elfström KM
PLoS Med; 2020 Jan; 17(1):e1003035. PubMed ID: 31990905
[TBL] [Abstract][Full Text] [Related]
2. Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening.
Poljak M
Clin Microbiol Infect; 2015 Sep; 21(9):806-7. PubMed ID: 26068650
[No Abstract] [Full Text] [Related]
3. The rationale for implementation of HPV testing in routine cervical screening in Romania.
Iancu LS; Ursu RG
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):293-6. PubMed ID: 24340506
[No Abstract] [Full Text] [Related]
4. Screening for cervical cancer and human papillomavirus vaccination in Israel: recommendations.
Bornstein J; Fisher WA; Ginsberg GM; Shavit O; Schejter E; Diaz M; Bosch FX
Vaccine; 2013 Nov; 31 Suppl 8():I58-60. PubMed ID: 24229721
[No Abstract] [Full Text] [Related]
5. Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries.
Luciani S; Jauregui B; Kieny C; Andrus JK
Immunotherapy; 2009 Sep; 1(5):795-807. PubMed ID: 20636024
[TBL] [Abstract][Full Text] [Related]
6. [Expert consensus on immunoprophylaxis of human papillomavirus-related diseases (abridged)].
Vaccine and Immunization Branch, Chinese Preventive Medicine Association
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Dec; 53(12):1218-1235. PubMed ID: 31795578
[TBL] [Abstract][Full Text] [Related]
7. The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
Hall MT; Smith MA; Lew JB; O'Hallahan J; Fentiman G; Neal H; Sage M; Canfell K
Gynecol Oncol; 2019 Mar; 152(3):472-479. PubMed ID: 30876491
[TBL] [Abstract][Full Text] [Related]
8. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.
Poljak M
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():64-9. PubMed ID: 22862799
[TBL] [Abstract][Full Text] [Related]
10. European consensus statement on "HPV Vaccination and Colposcopy".
Shafi MI; Petry U; Bosch XF; Gissman L; Kocken M; Helmerhorst TJ; Stanley M; Nazeer S; European Federation for Colposcopy
J Low Genit Tract Dis; 2011 Oct; 15(4):309-15. PubMed ID: 21959574
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Recent Advances in Molecular Detection of Human Papillomavirus and Cervical Cancer Screening.
Poljak M; Ginocchio CC
J Clin Virol; 2016 Mar; 76 Suppl 1():S1-S2. PubMed ID: 26597652
[No Abstract] [Full Text] [Related]
12. The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
Franco EL;
Cancer; 2023 Sep; 129(18):2765-2768. PubMed ID: 37347988
[No Abstract] [Full Text] [Related]
13. HPV testing and vaccination in Europe.
Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078
[TBL] [Abstract][Full Text] [Related]
14. HPV Vaccine, Especially Before Age 17, Is Associated with a Large Reduction in Invasive Cervical Cancer.
Ebell MH
Am Fam Physician; 2021 Mar; 103(5):312. PubMed ID: 33630552
[No Abstract] [Full Text] [Related]
15. Removing global barriers to cervical cancer prevention and moving towards elimination.
Alfaro K; Maza M; Cremer M; Masch R; Soler M
Nat Rev Cancer; 2021 Oct; 21(10):607-608. PubMed ID: 34376828
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of cervical cancer. Screening and vaccination: methods of use].
Boulanger JC
Gynecol Obstet Fertil; 2011; 39(7-8):405-6. PubMed ID: 21757389
[No Abstract] [Full Text] [Related]
19. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ
Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus: science and technologies for the elimination of cervical cancer.
Bosch FX
Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
